2024-03-29T04:56:16Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_D1F0737F890F
2024-03-23T03:01:15Z
serval:BIB_D1F0737F890F
Adjuvant dibromodulcitol and BCNU chemotherapy in anaplastic astrocytoma: results of a randomised European Organisation for Research and Treatment of Cancer phase III study (EORTC study 26882).
10.1016/j.ejca.2007.12.005
18248979
000257636900015
Hildebrand
J.
author
Gorlia
T.
author
Kros
J.M.
author
Afra
D.
author
Frenay
M.
author
Omuro
A.
author
Stupp
R.
author
Lacombe
D.
author
Allgeier
A.
author
van den Bent
M.J.
author
EORTC Brain Tumour Group investigators
contributor
Afra
D.
contributor
Maat
B.
contributor
Hildebrand
J.
contributor
de Wit
O.
contributor
Frenay
F.
contributor
Chatel
M.
contributor
Rivier
I.
contributor
Taphoorn
M.
contributor
Delattre
JY.
contributor
de Tribolet
N.
contributor
Stupp
R.
contributor
Punt
J.
contributor
Garfield
J.
contributor
Chinot
O.
contributor
van den Bent
M.
contributor
Lahrmann
H.
contributor
Cristo
C.
contributor
Mouchamps
M.
contributor
Haferkamp
G.
contributor
Bravo Marques
J.
contributor
article
2008
European Journal of Cancer
0959-8049
0959-8049
journal
44
9
1210-1216
Adult
Aged
Antineoplastic Combined Chemotherapy Protocols/therapeutic use
Astrocytoma/drug therapy
Astrocytoma/radiotherapy
Carmustine/administration & dosage
Carmustine/adverse effects
Chemotherapy, Adjuvant
Female
Hematologic Diseases/chemically induced
Humans
Kaplan-Meier Estimate
Male
Middle Aged
Mitolactol/administration & dosage
Mitolactol/adverse effects
Treatment Failure
eng
60_published
peer-reviewed
Publication types: Clinical Trial, Phase III ; Journal Article ; Multicenter Study ; Randomized Controlled Trial ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
Publication Status: ppublish